Zio XT ECG Monitoring System vs Study Watch with Irregular Pulse Monitor (Home)
AI Verdict
Choose Zio XT ECG Monitoring System if…
Choose Zio XT if your clinical objective is to achieve a definitive diagnosis of intermittent arrhythmias through continuous, high-compliance ECG monitoring for up to 14 days. Its leadless, water-resistant design ensures patient comfort and adherence, making it ideal for detecting elusive cardiac events in a real-world setting.
View Zio XT ECG Monitoring System →Choose Study Watch with Irregular Pulse Monitor (Home) if…
Choose the Verily Study Watch if your project involves clinical research or specialized healthcare applications requiring comprehensive physiological and environmental data collection beyond just continuous ECG. This prescription-only device is best suited for studies investigating correlations between on-demand ECG, irregular pulse, activity, and other contextual factors over an extended period.
View Study Watch with Irregular Pulse Monitor (Home) →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Zio XT ECG Monitoring System | Study Watch with Irregular Pulse Monitor (Home) |
|---|---|---|
| Pricing | Contact for pricing | Unknown |
| Deployment | Cloud-based (AWS EC2 platform), no on-premise hardware required. | Unknown |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Yes AI-estimated | Unknown |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Zio XT ECG Monitoring SystemTool A emphasizes patient comfort with a wire-free, water-resistant design for daily activities, leading to high reported compliance and satisfaction. Tool B, while designed to be unobtrusive, focuses on 'on-demand' ECG and clinical research, which may imply less emphasis on broad patient ease of use for routine, continuous monitoring.
Clinical Value
Zio XT ECG Monitoring SystemTool A provides continuous cardiac monitoring for up to 14 days with FDA-cleared AI and expert review specifically for accurate arrhythmia detection and diagnosis, offering a clear diagnostic pathway. Tool B offers broader physiological and environmental data, but its ECG is 'on-demand' and its primary use case is clinical research, potentially offering less comprehensive diagnostic data for continuous arrhythmia detection in routine clinical practice.
Pricing & Value
Zio XT ECG Monitoring SystemTool A offers transparent pricing details for both the UK and US markets, including established CPT codes for reimbursement, indicating a clear value proposition for clinical adoption. Tool B's pricing is not publicly available and is primarily for clinical research and prescription use, making its value for standard clinical practice difficult to assess.
Enterprise Readiness
Zio XT ECG Monitoring SystemTool A demonstrates strong enterprise readiness with explicit HIPAA compliance, a Business Associate Agreement (BAA), and deployment on a robust cloud platform (AWS EC2). While Tool B also claims HIPAA compliance and a BAA, the reported lawsuit alleging past HIPAA breaches introduces a potential concern regarding its long-term enterprise trust and data security posture.
Innovation
Study Watch with Irregular Pulse Monitor (Home)Tool B shows greater innovation by integrating a wider array of physiological and environmental sensors beyond just ECG, offering a more comprehensive and multi-modal approach to health data collection. While Tool A excels in extended continuous ECG monitoring with FDA-cleared AI, Tool B's broader sensing capabilities suggest more expansive future applications in health data capture.
Support & Docs
Zio XT ECG Monitoring SystemTool A explicitly highlights 'full support' for products, billing, and services, including a 24/7/365 specialized billing team and dedicated customer care lines for patients and professionals. Tool B provides various documentation and resources for its data platforms and regulatory information, but the direct, comprehensive, and always-available support for patients and billing, as offered by Tool A, appears more robust for a widely deployed clinical diagnostic service.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Zio XT ECG Monitoring System | Study Watch with Irregular Pulse Monitor (Home) |
|---|---|---|
| Device Name | Zio XT ECG Monitoring System | Study Watch with Irregular Pulse Monitor (Home) |
| Company | iRhythm Technologies | Verily Life Sciences LLC |
| Monitoring Duration | Up to 14 days continuous | Not specified |
| ECG Type | Wearable single-lead ECG biosensor | On-demand single-channel ECG measurement |
| Key Feature 1 | Continuous ambulatory cardiac monitoring for up to 14 days | Irregular pulse monitoring for atrial fibrillation (AFib) detection |
| Key Feature 2 | Water-resistant design for normal daily activities, including showering | Multiple physiological sensors (heart rate, electrodermal activity, inertial movements) |
| Key Feature 3 | Proprietary, FDA-cleared deep-learned AI algorithm for ECG data analysis | Long battery life (up to one week) |
Videos
Demos, reviews, and walkthroughs featuring Zio XT ECG Monitoring System and Study Watch with Irregular Pulse Monitor (Home).
Frequently Asked Questions
More Comparisons
More matchups featuring Zio XT ECG Monitoring System or Study Watch with Irregular Pulse Monitor (Home)
- Study Watch with Irregular Pulse Monitor (Home) vs Cardiomo
- Study Watch with Irregular Pulse Monitor (Home) vs PMcardio
- Study Watch with Irregular Pulse Monitor (Home) vs Sleepiz One+
- Study Watch with Irregular Pulse Monitor (Home) vs EchoNext
- Zio XT ECG Monitoring System vs EchoNext
- Zio XT ECG Monitoring System vs Sleepiz One+
Backers
Who funded each tool's parent company.